New Insulin Reform Gives a Shot in the Arm to the Health of Black Americans
COVID-19 has gripped national headlines for months. But long before the U.S. outbreak of the novel coronavirus, the country was battling another deadly epidemic: diabetes.
One of the leading causes of death in the United States, the disease claims the lives of more than 83,000 Americans each year. And -- much like the COVID-19 -- diabetes disproportionately impacts people of color.
That’s why it’s so encouraging that the Trump administration will soon make it easier for millions of diabetic Americans to manage their health. A recent proposal would cap the amount of money that Medicare beneficiaries pay out-ofpocket for insulin at $35.
That reform will go a long way towards getting older patients with diabetes the medicines they need to stay healthy -- a fact that’s certainly worth celebrating. But it’s only one step toward tackling a health crisis that shows no signs of relenting.
To read more please log in or subscribe to the digital edition https://etypeservices.com/The%20Canton%20TimesID209/